Learn more

METAGEN GESELLSCHAFT FUER GENOMFORSCHUNG MBH

Overview
  • Total Patents
    39
About

METAGEN GESELLSCHAFT FUER GENOMFORSCHUNG MBH has a total of 39 patent applications. Its first patent ever was published in 1998. It filed its patents most often in Germany, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are SHANGHAI MEDICAL UNIV, CCAM BIOTHERAPEUTICS LTD and CORVIDIA THERAPEUTICS INC.

Patent filings in countries

World map showing METAGEN GESELLSCHAFT FUER GENOMFORSCHUNG MBHs patent filings in countries

Patent filings per year

Chart showing METAGEN GESELLSCHAFT FUER GENOMFORSCHUNG MBHs patent filings per year from 1900 to 2020

Focus industries

Top inventors

# Name Total Patents
#1 Schmitt Armin 38
#2 Hinzmann Bernd 38
#3 Specht Thomas 38
#4 Pilarsky Christian 38
#5 Dahl Edgar 38
#6 Rosenthal Andre 37
#7 Rosenthal Andre Prof Dr 1
#8 Hinzmann Bernd Dr 1
#9 Specht Thomas Dr 1
#10 Pilarsky Christian Dr 1

Latest patents

Publication Filing date Title
DE19820190A1 Human pancreatic tumor nucleic acid sequences
DE19818620A1 New polypeptides and their nucleic acids, useful for treatment of bladder tumor and identification of therapeutic agents
DE19818619A1 New nucleic acid sequences expressed in bladder tumor tissue, and derived polypeptides, for treatment of bladder tumor and identification of therapeutic agents
DE19818598A1 New nucleic acid sequences expressed in normal pancreatic tissues, and derived polypeptides, for treatment of pancreatic cancer and identification of therapeutic agents
DE19817947A1 New nucleic acid sequences expressed in uterine myoma, and derived polypeptides, for treatment of uterine carcinoma and identification of therapeutic agents
DE19817948A1 New nucleic acid sequences expressed in uterine cancer tissues, and derived polypeptides, for treatment of uterine and endometrial cancer and identification of therapeutic agents
DE19817946A1 New nucleic acid sequences expressed in normal uterine tissues, and derived polypeptides, for treatment of uterine cancer and identification of therapeutic agents
DE19817557A1 Human nucleic acid sequences from ovarian tumor tissue
DE19816395A1 Human nucleic acid sequences from ovarian normal tissue
DE19813835A1 Human nucleic acid sequences and protein products from normal breast tissue, useful for breast cancer therapy
DE19813839A1 Human nucleic acid sequences and protein products from tumor breast tissue, useful for breast cancer therapy
DE19811194A1 New nucleic acid expressed at high level in normal prostatic tissue and encoded polypeptides, used to treat cancer and screen for therapeutic agents
DE19811193A1 New nucleic acid expressed at high level in prostatic tumor tissue and encoded polypeptides, useful for treating cancer and screening for therapeutic agents